Table 5.
Animals | Route of Administration |
Treatment | Brain Tissue | Identified Metabolites in Brain |
Plasma Concentratio |
Refs |
---|---|---|---|---|---|---|
male C57BL/6 mice (7 months, 25–30 g) |
i.g. | UroA 0.3 mg/mouse, single administration |
brain tissues | mUroA: 8 ng/g | --- | [147] |
male C57BL/6 mice (6 weeks) |
i.g. | UroA 200 mg/kg b.w., single administration |
cortex | UroA: 28 ng/g | 15 ng/mL | [148] |
hippocampus | UroA: 35 ng/g | |||||
male rats (12 weeks, 288 ± 20 g) |
i.v. | Polyphenol metabolites (12.5 μg UroA + 5.3 μgUroB) 2.7 µmol/rat/day for 2 days |
brain tissues | UroA: 2.2 ng/g | --- | [41] |
UroB: 0.5 ng/g | ||||||
male albino Wistar rats (6 weeks, 250–300 g) |
i.g. | Pomegranate juice 500 mg/kg b.w./day for 10 days |
brain tissues | UroA: 1.68 ± 0.25 ng/g | 18.75 ± 3.21 ng/mL | [36] |
male albino Wistar rats (6 weeks, 250–300 g) |
i.g. | Pomegranate juice 500 mg/kg b.w./day for 45 days |
brain tissues | UroA: 2.068 ± 0.274 ng/g | --- | [149] |
Abbreviations: i.v.: intravenous, i.g.: intragastrical, b.w.: body weight.